Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to IL-22 and IL-22R

Details for Australian Patent Application No. 2006342792 (hide)

Owner Genentech, Inc.

Inventors Wu, Jianfeng; Chuntharapai, Anan; Zheng, Yan; Ouyang, Wenjun; Chen, Yvonne; Wong, Terence; Valdez, Patricia; Sa, Susan; Danilenko, Dimitry

Agent Griffith Hack

Pub. Number AU-A-2006342792

PCT Pub. Number WO2007/126439

Priority 60/741,640 02.12.05 US; 60/822,597 16.08.06 US

Filing date 30 November 2006

Wipo publication date 8 November 2007

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/126439 Priority application(s): WO2007/126439

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006342794-Back-contact photovoltaic cells

2006342790-Systems and methods for emphasized cytological specimen review